Understanding myofibroblast origin in the fibrotic lung

Area of Science:

• Pulmonary Medicine
• Cell Biology
• Fibrosis Research

Background:

• Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease characterized by myofibroblast (MYF) accumulation and extracellular matrix deposition.
• MYFs are implicated in the distortion and scarring of lung alveoli, leading to respiratory failure.
• Understanding the cellular origins of MYFs is crucial for developing targeted therapies for IPF.

Purpose of the Study:

• To review the current understanding of myofibroblast (MYF) biology in idiopathic pulmonary fibrosis (IPF).
• To discuss recent advances in identifying the cellular precursors and heterogeneity of MYFs.
• To highlight emerging therapeutic strategies for IPF based on MYF research.

Main Methods:

• Review of recent basic and translational research.
• Analysis of studies employing lineage tracing techniques.
• Inclusion of multi-omics approaches to investigate MYF precursors and fate.

Main Results:

• Recent research has shed light on the cellular origins and heterogeneity of MYFs in IPF.
• Lineage tracing and multi-omics have advanced the identification of MYF precursors.
• Insights into MYF fate during fibrosis resolution are emerging.

Conclusions:

• Identifying the cellular source of MYFs is key to developing novel therapeutic targets for IPF.
• Advances in understanding MYF biology are paving the way for new IPF treatments.
• Further research into MYF heterogeneity and fate may lead to more effective therapeutic strategies.